Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Finished Goods (2022 - 2025)

Envoy Medical's Finished Goods history spans 4 years, with the latest figure at $196000.0 for Q4 2025.

  • Quarterly results put Finished Goods at $196000.0 for Q4 2025, up 64.71% from a year ago — trailing twelve months through Dec 2025 was $196000.0 (up 64.71% YoY), and the annual figure for FY2025 was $196000.0, up 64.71%.
  • Finished Goods for Q4 2025 was $196000.0 at Envoy Medical, up from $165000.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $196000.0 in Q4 2025 to a low of $84000.0 in Q4 2023.
  • The 4-year median for Finished Goods is $121000.0 (2022), against an average of $129818.2.
  • The sharpest move saw Finished Goods plummeted 30.58% in 2023, then soared 64.71% in 2025.
  • Year by year, Finished Goods stood at $121000.0 in 2022, then plummeted by 30.58% to $84000.0 in 2023, then soared by 41.67% to $119000.0 in 2024, then soared by 64.71% to $196000.0 in 2025.
  • According to Business Quant data, Finished Goods over the past three periods came in at $196000.0, $165000.0, and $120000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.